Kadimastem (Israel) Probability of Future Stock Price Finishing Under 906.20
| KDST Stock | ILA 1,189 14.00 1.19% |
Kadimastem |
Kadimastem Target Price Odds to finish below 906.20
The tendency of Kadimastem Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to drop to 906.20 or more in 90 days |
| 1,189 | 90 days | 906.20 | about 44.26 |
Based on a normal probability distribution, the odds of Kadimastem to drop to 906.20 or more in 90 days from now is about 44.26 (This Kadimastem probability density function shows the probability of Kadimastem Stock to fall within a particular range of prices over 90 days) . Probability of Kadimastem price to stay between 906.20 and its current price of 1189.0 at the end of the 90-day period is about 36.92 .
Assuming the 90 days trading horizon Kadimastem has a beta of 0.24. This indicates as returns on the market go up, Kadimastem average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding Kadimastem will be expected to be much smaller as well. Moreover Kadimastem has an alpha of 1.4248, implying that it can generate a 1.42 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta). Kadimastem Price Density |
| Price |
Predictive Modules for Kadimastem
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Kadimastem. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Kadimastem Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Kadimastem is not an exception. The market had few large corrections towards the Kadimastem's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Kadimastem, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Kadimastem within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 1.42 | |
β | Beta against Dow Jones | 0.24 | |
σ | Overall volatility | 274.54 | |
Ir | Information ratio | 0.18 |
Kadimastem Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Kadimastem for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Kadimastem can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Kadimastem is way too risky over 90 days horizon | |
| Kadimastem appears to be risky and price may revert if volatility continues | |
| Kadimastem has accumulated 12.96 M in total debt with debt to equity ratio (D/E) of 7.8, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Kadimastem has a current ratio of 0.38, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist Kadimastem until it has trouble settling it off, either with new capital or with free cash flow. So, Kadimastem's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Kadimastem sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Kadimastem to invest in growth at high rates of return. When we think about Kadimastem's use of debt, we should always consider it together with cash and equity. | |
| Net Loss for the year was (26.27 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Kadimastem has accumulated about 5.43 M in cash with (21.55 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.28. | |
| Roughly 54.0% of Kadimastem outstanding shares are owned by corporate insiders |
Kadimastem Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Kadimastem Stock often depends not only on the future outlook of the current and potential Kadimastem's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Kadimastem's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 33.7 M |
Kadimastem Technical Analysis
Kadimastem's future price can be derived by breaking down and analyzing its technical indicators over time. Kadimastem Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Kadimastem. In general, you should focus on analyzing Kadimastem Stock price patterns and their correlations with different microeconomic environments and drivers.
Kadimastem Predictive Forecast Models
Kadimastem's time-series forecasting models is one of many Kadimastem's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Kadimastem's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Kadimastem
Checking the ongoing alerts about Kadimastem for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Kadimastem help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Kadimastem is way too risky over 90 days horizon | |
| Kadimastem appears to be risky and price may revert if volatility continues | |
| Kadimastem has accumulated 12.96 M in total debt with debt to equity ratio (D/E) of 7.8, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Kadimastem has a current ratio of 0.38, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist Kadimastem until it has trouble settling it off, either with new capital or with free cash flow. So, Kadimastem's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Kadimastem sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Kadimastem to invest in growth at high rates of return. When we think about Kadimastem's use of debt, we should always consider it together with cash and equity. | |
| Net Loss for the year was (26.27 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Kadimastem has accumulated about 5.43 M in cash with (21.55 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.28. | |
| Roughly 54.0% of Kadimastem outstanding shares are owned by corporate insiders |
Other Information on Investing in Kadimastem Stock
Kadimastem financial ratios help investors to determine whether Kadimastem Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Kadimastem with respect to the benefits of owning Kadimastem security.